155 related articles for article (PubMed ID: 1555609)
21. [Value of vasoactive drugs in conservative therapy of peripheral arterial occlusive disease].
Scheffler A; Rieger H
Z Arztl Fortbild Qualitatssich; 1999 Nov; 93(9):639-44. PubMed ID: 10666827
[TBL] [Abstract][Full Text] [Related]
22. Treatment of peripheral arterial insufficiency with inositoli nicotinas (Hexanicit).
Hentzer E
Scand J Clin Lab Invest Suppl; 1967; 99():226-32. PubMed ID: 4862834
[No Abstract] [Full Text] [Related]
23. Guidelines for therapeutic studies on peripheral arterial occlusive disease in Fontaine stages II-IV. German society of Angiology.
Heidrich H; Allenberg J; Cachovan M; Creutzig A; Diehm C; Gruss J; Kriessmann A; Rieger H; Rudofsky G; Trampisch HJ
Vasa; 1992; 21(4):333-43. PubMed ID: 1485465
[No Abstract] [Full Text] [Related]
24. [Contraindicated medical references and vasoactive agents in arterial pathology of the lower limbs].
Boccalon H
Rev Med Interne; 1999 Jan; 20(1):68-73. PubMed ID: 10220823
[TBL] [Abstract][Full Text] [Related]
25. [Peripheral arterial disease: Treatment].
Desormais I; Aboyans V; Pesteil F; Lacroix P
Presse Med; 2018 Jan; 47(1):56-61. PubMed ID: 29273182
[TBL] [Abstract][Full Text] [Related]
26. Medical treatment of peripheral arterial disease and claudication.
Hiatt WR
N Engl J Med; 2001 May; 344(21):1608-21. PubMed ID: 11372014
[No Abstract] [Full Text] [Related]
27. Pentoxifylline treatment of moderate to severe chronic occlusive arterial disease.
Lee BY; Berkowitz P; Savitsky JP; May GS; Brobst J; McCann WJ
Clin Cardiol; 1985 Mar; 8(3):161-5. PubMed ID: 3978888
[TBL] [Abstract][Full Text] [Related]
28. Ticlopidine in the treatment of peripheral occlusive arterial disease.
Arcan JC; Panak E
Semin Thromb Hemost; 1989 Apr; 15(2):167-70. PubMed ID: 2665087
[No Abstract] [Full Text] [Related]
29. [Anticoagulation and antiaggregation in patients with peripheral arterial occlusive diseases].
Dörffler-Melly J; Schmidli J; Mahler F
Ther Umsch; 2003 Jan; 60(1):36-42. PubMed ID: 12638477
[TBL] [Abstract][Full Text] [Related]
30. An evaluation of vasodilator drugs in occlusive vascular disease by measurement.
Gillespie JA
Angiology; 1966 May; 17(5):280-8. PubMed ID: 5936944
[No Abstract] [Full Text] [Related]
31. [Evaluation of cutaneous necrosis risk in peripheral arterial diseases].
D'Eri A; Martini R; Cordova RM; Trevisan G; Andreozzi GM
Minerva Cardioangiol; 2002 Jun; 50(3):239-44. PubMed ID: 12107403
[TBL] [Abstract][Full Text] [Related]
32. Management of peripheral arterial disease and intermittent claudication.
Schainfeld RM
J Am Board Fam Pract; 2001; 14(6):443-50. PubMed ID: 11757887
[TBL] [Abstract][Full Text] [Related]
33. [Peripheral arterial occlusive disease (PAVK)].
Anand S; Creager M
Vasa; 2003 Aug; 32(3):179-80. PubMed ID: 14524043
[No Abstract] [Full Text] [Related]
34. [Cilostazol is effective and safe option for the treatment of intermittent claudication. Results of the NOCLAUD study].
Farkas K; Járai Z; Kolossváry E
Orv Hetil; 2017 Jan; 158(4):123-128. PubMed ID: 28116935
[TBL] [Abstract][Full Text] [Related]
35. The role of cilostazol (Pletal) in the management of intermittent claudication.
Bradbury AW
Int J Clin Pract; 2003 Jun; 57(5):405-9. PubMed ID: 12846346
[TBL] [Abstract][Full Text] [Related]
36. [Heparan sulphate in association with indobufen in the treatment of chronic peripheral obliterative arteriopathy of the lower extremities. Controlled clinical trial].
Rossini A; Tascino C; Costa F
Minerva Cardioangiol; 1998 Nov; 46(11):457-69. PubMed ID: 10207294
[TBL] [Abstract][Full Text] [Related]
37. Current and future drug therapies for claudication.
Hiatt WR
Vasc Med; 1997; 2(3):257-62. PubMed ID: 9546977
[TBL] [Abstract][Full Text] [Related]
38. Drugs in cerebral and peripheral arterial disease.
Lowe GD
BMJ; 1990 Feb; 300(6723):524-8. PubMed ID: 2107935
[No Abstract] [Full Text] [Related]
39. [Peripheral arterial disease with lower limb claudication: Medical treatment].
Long A; Bui HT; Journet J; Hadj Henni A
J Mal Vasc; 2009 Nov; 34(5):323-9. PubMed ID: 19713062
[TBL] [Abstract][Full Text] [Related]
40. Prostanoid drug therapy for peripheral arterial occlusive disease--the European experience.
Dormandy JA
Vasc Med; 1996; 1(2):155-8. PubMed ID: 9546931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
